← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

CFO Howard Horn sold $98K of Ultragenyx Pharmaceutical Inc.

Sold$98,203
$20.97Price
4,683Shares
−6%Stake

What RARE did after the filing

Filed Apr 2Copier in Apr 6
The stock from Mon, Apr 6 open, $22.45
+7.8%
S&P 500, same days
+12.6%

Measured over 30 trading days, to the May 18 close.

Traded Wed, Apr 1. Filed Thu, Apr 2, 6:19 PM ET, after the close. Returns use the Apr 6 open and the May 18 close. Not investment advice.